Skip to main content
Clinical Trials/CTRI/2020/02/023631
CTRI/2020/02/023631RecruitingPhase 3

A study evaluating the efficacy of Axillary Reverse Mapping in biopsy proven patients undergoing upfront surgery - ARM

Tata Memorial Centre0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Biopsy confirmed early breast cancer with clinical N0/N1 axilla

Exclusion Criteria

  • 1. Matted nodes in the axilla or locally advanced breast cancer
  • 2.Prior surgeries in the upper limb, axilla or breast
  • 3.Prior treatment for breast cancer including neoadjuvant chemotherapy
  • 4.Pregnant woman
  • 5. Allergies to Indocyanine dye or blue dye

Investigators

Similar Trials